Pantazis N, Kenward MG, Touloumi G. Performance of parametric survival models under non-random interval censoring: A simulation study. Computational statistics & data analysis. 2013;63:16–30.

Lodi S, Fisher M, Phillips A, de Luca A, Ghosn J, Malyuta R, Zangerle R, Moreno S, Vanhems P, Boufassa F, et al. Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection. PloS one. 2013;8:e78642.

Paraskevis D, Touloumi G, Bakoyannis G, Paparizos V, Lazanas M, Gargalianos P, Chryssos G, Antoniadou A, Psichogiou M, Panos G, et al. Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals. AIDS research and human retroviruses. 2013;29:461–469.

Touloumi G, Pantazis N, Chaix M-L, Bucher HC, Zangerle R, Kran A-MB, Thiebaut R, Masquelier B, Kucherer C, d'Arminio Monforte A, et al. Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration. PloS one. 2013;8:e71174.

Rosinska M, Marzec-Bogustawska A, Janiec J, Smolen-Dzirba J, Wkasik T, Gniewosz J, Zalewska M, Murphy G, McKinney E, Porter K. High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland. AIDS research and human retroviruses. 2013;29:805–813.

Lodi S, Del Amo J, d'Arminio Monforte A, Abgrall S, Sabin C, Morrison C, Furrer H, Muga R, Porter K, Girardi E, et al. Risk of tuberculosis following HIV seroconversion in high-income countries. Thorax. 2013;68:207–213.

Farmakis E-TR, Beer F, Kozyrakis K, Pantazis N, Moritz A. The influence of different power settings of Nd: YAG laser irradiation, bioglass and combination to the occlusion of dentinal tubules. Photomedicine and laser surgery. 2013;31:54–58.

Farmakis ETR, Sotiropoulos GG, Pantazis N, Kozyrakis K. The permanent deformation of the self-adjusting files when used in canals of extracted teeth. International endodontic journal. 2013;46:863–869.

Madec Y, Boufassa F, Porter K, Prins M, Sabin C, d’Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, et al. Natural history of HIV-control since seroconversion. Aids. 2013;27:2451–2460.

Huang X, Lodi S, Fox Z, Li W, Phillips A, Porter K, Lutsar I, Kelleher A, Li N, Xu X, et al. Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013;62:441–446.

van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chene G, Dorrucci M, Muga R, Porter K, Prins M, et al. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. Gastroenterology. 2013;144:751–760.